CJC-1295 NO DAC + IPA
CJC-1295 5 mg + Ipamorelin 5 mg
≥ 99.3% · Lyophilized powder
- HPLC-verified purity — ≥ 99.3% on this lot
- Lot-numbered — Lot 0483 — traceable end to end
- North American manufactured — Shipped from Ontario, Canada
FOR RESEARCH USE ONLY · NOT INTENDED FOR HUMAN CONSUMPTION. Sold for laboratory and research purposes only.
What's in the vial.
- Compound
- CJC-1295 NO DAC + IPA
- Lane
- Stacks
- Composition
- CJC-1295 5 mg + Ipamorelin 5 mg
- Available sizes
- 5 mg + 5 mg
- Purity (HPLC)
- ≥ 99.3%
- Form
- Lyophilized powder
- Lot
- 0483
- Storage
- Cold, away from light
Co-supplied preparation of CJC-1295 (No DAC) and Ipamorelin. Supplied as lyophilized powder for laboratory research use only. Independently assayed for purity and identity.
CJC-1295 NO DAC + IPA.
A co-supplied preparation of CJC-1295 (No DAC) and Ipamorelin in equal parts — a GHRH analogue paired with a selective ghrelin-receptor agonist.
Research context
The standard pairing in growth-hormone pathway research.
Handling & storage
Reconstitute with bacteriostatic water. Store lyophilized powder at −20 °C; keep reconstituted solution at 2–8 °C, protected from light.
Note
Descriptions are provided for laboratory reference only and describe the compound and the research field in which it appears. Nothing here is a recommendation, protocol, or statement of effect.
